Biora Therapeutics earnings were -$86.6M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest BIOR earnings report on Jun 30, 2024 announced Q2 2024 earnings of $6.5M, down 254.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, BIOR reported annual earnings of -$124.1M, with 225.3% growth. The next BIOR earnings date is Nov 11, 2024.
What were Biora Therapeutics's earnings last quarter?
On BIOR's earnings call on Invalid Date, Biora Therapeutics (NASDAQ: BIOR) reported Q2 2024 earnings per share (EPS) of $0.18, up 112.24% year over year. Total BIOR earnings for the quarter were $6.47 million. In the same quarter last year, Biora Therapeutics's earnings per share (EPS) was -$1.47.
The next BIOR earnings date is Invalid Date. Add BIOR to your watchlist to be reminded of Biora Therapeutics's next earnings date.
Is Biora Therapeutics profitable or losing money?
As of the last Biora Therapeutics earnings report, Biora Therapeutics is currently losing money. Biora Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$86.59 million, a 60.1% increase year over year.
What was BIOR's earnings growth in the past year?
As of Biora Therapeutics's earnings date in Invalid Date, Biora Therapeutics's earnings has grown year over year. BIOR earnings in the past year totalled -$86.59 million.
What are Biora Therapeutics's earnings expectations?
The current EPS estimate for Biora Therapeutics's earnings report in Invalid Date is -$0.38.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.